Using sequence data to infer the antigenicity of influenza virus

mBio

Volumn 4, Issue 4, 2013, Pages

  Sun, Hailiang ^a   Yang, Jialiang ^a   Zhang, Tong ^b   Long, Li Ping ^a   Jia, Kun ^a   Yang, Guohua ^a   Webby, Richard J ^c   Wan, Xiu Feng ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ANTIGEN DETECTION; ANTIGENICITY; ARTICLE; BOOTSTRAPPING; CLUSTER ANALYSIS; GENE MAPPING; GENETIC DISTANCE; GENETIC DRIFT; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS IDENTIFICATION; VIRUS STRAIN;

ORTHOMYXOVIRIDAE;

EID: 84883422966     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00230-13     Document Type: Article

References (51)

1. CDC. 2010. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb. Mortal. Wkly. Rep. 59: 1057-1062.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186.
3. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. 2004. Influenza-associated hospitalizations in the United States. JAMA 292:1333-1340.
4. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB, Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). 2004. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep 53:1-40.
5. Wilson IA, Cox NJ. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737-771.
6. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
7. WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W, Zhang W. 2012. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respi. Viruses 6:142-152.
8. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N. 2002. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc. Natl. Acad. Sci. U. S. A. 99:10748-10752.
9. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. 2000. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccineinduced antibody response to this strain in the elderly. J. Med. Virol. 61:94-99.
10. Lee MS, Chen JS. 2004. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg. Infect. Dis. 10(8):1385-1390.
11. CDC. 2012. Update: influenza A (H3N2)v transmission and guidelines-five states, 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1741-1744.
12. Huang JW, King CC, Yang JM. 2009. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics 10(Suppl 1):S41.
13. Mansfield KG. 2007. Viral tropism and the pathogenesis of influenza in the mammalian host. Am. J. Pathol. 171:1089-1092.
14. Cai Z, Zhang T, Wan XF. 2010. A computational framework for influenza antigenic cartography. PLoS Comput. Biol. 6:e1000949. doi: 10.1371/ journal.pcbi.1000949.
15. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Jr, Wilson IA. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357-360.
16. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
17. Shih AC, Hsiao TC, Ho MS, Li WH. 2007. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc. Natl. Acad. Sci. U. S. A. 104:6283-6288.
18. Jin H, Zhou H, Liu H, Chan W, Adhikary L, Mahmood K, Lee MS, Kemble G. 2005. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/ 2007/99. Virology 336:113-119.
19. Zhou R, Das P, Royyuru AK. 2008. Single mutation induced H3N2 hemagglutinin antibody neutralization: a free energy perturbation study. J. Phys. Chem. B 112:15813-15820.
20. Ansaldi F, Icardi G, Gasparini R, Campello C, Puzelli S, Bella A, Donatelli I, Salmaso S, Crovari P. 2005. New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season. J. Clin. Microbiol. 43:3027-3029.
21. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. 1999. Predicting the evolution of human influenza A. Science 286:1921-1925.
22. Rubinstein ND, Mayrose I, Halperin D, Yekutieli D, Gershoni JM, Pupko T. 2008. Computational characterization of B-cell epitopes. Mol. Immunol. 45:3477-3489.
23. Air GM, Laver WG, Webster RG. 1990. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase. J. Virol. 64:5797-5803.
24. Shu B, Garten R, Emery S, Balish A, Cooper L, Sessions W, Deyde V, Smith C, Berman L, Klimov A, Lindstrom S, Xu X. 2012. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology 422: 151-160.
25. Smith DJ, Forrest S, Ackley DH, Perelson AS. 1999. Variable efficacy of repeated annual influenza vaccination. Proc. Natl. Acad. Sci. U. S. A. 96: 14001-14006.
26. Liao YC, Lee MS, Ko CY, Hsiung CA. 2008. Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24:505-512.
27. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, Centers for Disease Control and Prevention (CDC). 2010. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm. Rep. 59:1-62.
28. CDC. 2012. Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count-United States, 2012. MMWR Morb. Mortal. Wkly. Rep. 61:619-621.
29. Cai Z, Ducatez MF, Yang J, Zhang T, Long LP, Boon AC, Webby RJ, Wan XF. 2012. Identifying antigenicity-associated sites in highly pathogenic H5N1 influenza virus hemagglutinin by using sparse learning. J. Mol. Biol. 422:145-155.
30. Ndifon W, Wingreen NS, Levin SA. 2009. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl. Acad. Sci. U. S. A. 106:8701-8706.
31. Stevens J, Chen LM, Carney PJ, Garten R, Foust A, Le J, Pokorny BA, Manojkumar R, Silverman J, Devis R, Rhea K, Xu X, Bucher DJ, Paulson JC, Cox NJ, Klimov A, Donis RO. 2010. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J. Virol. 84:8287-8299.
32. Westgeest KB, de Graaf M, Fourment M, Bestebroer TM, van Beek R, Spronken MI, de Jong JC, Rimmelzwaan GF, Russell CA, Osterhaus AD, Smith GJ, Smith DJ, Fouchier RA. 2012. Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution. J. Gen. Virol. 93: 1996-2007.
33. Johansson BE, Moran TM, Kilbourne ED. 1987. Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenzaAvirus surface glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 84:6869-6873.
34. Morishita T, Nobusawa E, Nakajima K, Nakajima S. 1996. Studies on the molecular basis for loss of the ability of recent influenza A (H1N1) virus strains to agglutinate chicken erythrocytes. J. Gen. Virol. 77:2499-2506.
35. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. 2000. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 278:587-596.
36. Valdar WS. 2002. Scoring residue conservation. Proteins 48:227-241.
37. Smith RF, Smith TF. 1992. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. Protein Eng. 5:35-41.
38. Tibshirani R. 1996. Regression shrinkage and selection via the LASSO. J. R. Stat. Soc. B Stat. Methodol. 58:267-288.
39. Fraczkiewicz R, Braun W. 1998. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J. Comput. Chem. 19:319-333.
40. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. 2008. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26(Suppl 4):D31-D34.
41. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D. 2008. The influenza virus resource at the National Center for Biotechnology Information. J. Virol. 82:596-601.
42. Garnier JL, Merino R, Kimoto M, Izui S. 1988. Resistance to tolerance induction to human gamma globulin (HGG) in autoimmune BXSB/MpJ mice: functional analysis of antigen-presenting cells and HGG-specific T helper cells. Clin. Exp. Immunol. 73:283-288.
43. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797.
44. Barnett JL, Yang J, Cai Z, Zhang T, Wan XF. 2012. AntigenMap 3D: an online antigenic cartography resource. Bioinformatics 28:1292-1293.
45. Triana-Baltzer GB, Gubareva LV, Klimov AI, Wurtman DF, Moss RB, Hedlund M, Larson JL, Belshe RB, Fang F. 2009. Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One 4:e7838. doi: 10.1371/journal.pone.0007838.
46. Chan RW, Chan MC, Wong AC, Karamanska R, Dell A, Haslam SM, Sihoe AD, Chui WH, Triana-Baltzer G, Li Q, Peiris JS, Fang F, Nicholls JM. 2009. DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob. Agents Chemother. 53:3935-3941.
47. Zwickl DJ. 2006. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. University of Texas at Austin, Austin, TX.
48. Swofford DL. 1998. PAUP*: phylogenic analysis using parsimony. Sinauer, Sunderland, MA.
49. Ducatez MF, Cai Z, Peiris M, Guan Y, Ye Z, Wan XF, Webby RJ. 2011. Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses. J. Clin. Microbiol. 49:3531-3536.
50. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
51. Lindstrom S, Garten R, Balish A, Shu B, Emery S, Berman L, Barnes N, Sleeman K, Gubareva L, Villanueva J, Klimov A. 2012. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg. Infect. Dis. 18:834-837.